Kamada Ltd. (KMDA)
NASDAQ: KMDA · Real-Time Price · USD
7.85
-0.58 (-6.88%)
At close: May 13, 2026, 4:00 PM EDT
7.86
+0.01 (0.13%)
After-hours: May 13, 2026, 4:10 PM EDT
Kamada Revenue
In the year 2025, Kamada had annual revenue of $180.46M with 12.12% growth. Kamada had revenue of $44.68M in the quarter ending December 31, 2025, with 14.54% growth.
Revenue (ttm)
$180.46M
Revenue Growth
+12.12%
P/S Ratio
2.49
Revenue / Employee
$390,606
Employees
462
Market Cap
449.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 180.46M | 19.51M | 12.12% |
| Dec 31, 2024 | 160.95M | 18.43M | 12.93% |
| Dec 31, 2023 | 142.52M | 13.18M | 10.19% |
| Dec 31, 2022 | 129.34M | 25.70M | 24.79% |
| Dec 31, 2021 | 103.64M | -29.60M | -22.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tilray Brands | 858.28M |
| Amphastar Pharmaceuticals | 720.53M |
| Emergent BioSolutions | 676.80M |
| Organogenesis Holdings | 514.70M |
| Esperion Therapeutics | 418.24M |
| Ironwood Pharmaceuticals | 361.51M |
| Evolus | 301.79M |
| Akebia Therapeutics | 232.40M |
KMDA News
- 7 hours ago - Kamada (KMDA) Maintains 2026 Financial Projections - GuruFocus
- 7 hours ago - Kamada (KMDA) Reports Strong Q1 Revenue Growth - GuruFocus
- 8 hours ago - Kamada Releases Q1 2026 Financial Results - AlphaStreet
- 9 hours ago - Kamada Earnings Call Transcript: Q1 2026 - Transcripts
- 9 hours ago - Kamada reports Q1 EPS 7c, consensus 12c - TheFly
- 9 hours ago - Kamada backs FY26 revenue view $200M-$205M - TheFly
- 10 hours ago - Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year - GlobeNewsWire
- 5 days ago - Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key Metrics - Nasdaq